【摘 要】
:
To examine if diabetes affects the seniors mortality from pneumonia, the US NHANES Ⅲ follow-up study data was used.After cleaning those who were other minorities, had been hospitalized for pneumonia i
【机 构】
:
Brock University Canada
【出 处】
:
MIT`s 1st Annual World Congress of Diabetes-2012(2012第一届糖尿病大
论文部分内容阅读
To examine if diabetes affects the seniors mortality from pneumonia, the US NHANES Ⅲ follow-up study data was used.After cleaning those who were other minorities, had been hospitalized for pneumonia in previous year or whose death cause was due to pneumonia during the first year of follow-up, a total of 3707 aged 65 years or older seniors (1794 men and 1913 women) who had no missing information on variables for the analysis were included in this report.Diabetes was defined at the baseline as either having been diagnosed as diabetes by a physician or current taking insulin or pills to lowering blood glucose or HbA lc higher than 6.5 at the baseline.16.4% of subjects in this sample were identified as having diabetes.During approximately average 10.7 years follow-up, a total of 98 deaths were recorded as due to pneumonia (ICD-10:J12-J18) with a mortality rate at 2.2 per 10,000 person year.After adjustment for the covariates at the baseline, which include age, gender, ethnicity, cigarette smoking, education, BMI, diastolic blood pressure, comorbidity (heart attack, cancers, hypertension or stroke), health status, other respiratory problems (asthma, chronic bronchitis, wheezing or whistling during last year), and whether blood glucose being controlled, the result from Cox-regression analysis showed that in comparing to those without diabetes, the hazard ratio of dying from pneumonia was 2.67 (95% confidence interval: 1.18, 6.05, p-value<0.05) for those seniors with diabetes.This suggests that diabetes in seniors is an important risk for pneumonia mortality.
其他文献
Background The race of African American along with obesity, physical inactivity, and family history of metabolic disorders is the risk factors for type 2 diabetes (T2D) in the United States.However, l
As of2011, approximately 336 million people worldwide have diabetes-most needing to produce more insulin because of insulin resistance, yet nearly all with pancreatic β-cell dysfunction.In β-cells, in
Toll-like receptors (TLR) act as early sensors of microbial pathogens, but accumulating evidence indicates that they also have an important role in autoimmunity.In particular, manipulation of TLRs in
Aims/hypothesis This meta-analysis aimed to compare the renal outcomes between ACE inhibitor (ACEI)/angiotensin Ⅱ receptor blocker (ARB) and other antihypertensive drugs or placebo in type 2 diabetes.
Insulin sensitizers treat a root cause of type 2 diabetes and have not only the potential to durably treat, but to actually prevent diabetes.Unfortunately, only three insulin sensitizers have been app
There is considerable confusion regarding outcome from randomised controlled trials (RCT) using fibrates.Even after more than 20 years of widespread use of fibrates we are still dealing with uncertain
Background: Demethylasterriquinone (DMAQ) B 1, extracted from tropical fungus, Pseudomassaria sp., is an orally effective compound at lowering blood glucose levels in diabetic (db/db) mice;however, th
Lipotoxicity is a key event in diabesity and vascular diseases associated with cytotoxicity, inflammation and apoptosis/proliferation.Plasma lipid species reflect cell/organelle dysfunctions and respo
1.Basal insulin requirement is approximately 30% of the total daily insulin dose in type 1 diabetic patients who use the insulin pump.To investigate the basal insulin requirement in total daily insuli
We studied whether serum fasting levels of active form of peptide YY (PYY), PYY(3-36), are associated with obesity and related phenotypes.Study population consisted of 428 patients with coronary arter